Trinity Biotech PLC

195 articles about Trinity Biotech PLC

• Trinity Biotech to Announce Third Quarter 2010 Financial Results

  10/11/2010

• Trinity Biotech Announces Quarter 2 Financial Results

  7/29/2010

• Trinity Biotech to Announce Second Quarter 2010 Financial Results

  7/14/2010

• Trinity Biotech Announces Quarter 1 Financial Results

  5/11/2010

• Trinity Biotech Closes Deal to Sell Its Worldwide Coagulation Business Line to Stago for $90 Million

  5/5/2010

• Trinity Biotech to Announce First Quarter 2010 Financial Results

  4/22/2010

• Trinity Biotech Announces Quarter 4 Financial Results EPS Increases From 7.1 Cent to 15.5 Cent and Disposal of Coagulation Business Line to Stago

  3/11/2010

• Trinity Biotech Announces Third Quarter 2009 Financial Results

  10/21/2009

• Trinity Biotech to Announce Third Quarter 2009 Financial Results on October 21, 2009

  10/14/2009

• Trinity Biotech Announces Second Quarter 2009 Financial Results

  7/23/2009

• Trinity Biotech Announces TRI-stat(TM) CLIA Submission to FDA

  7/20/2009

• Trinity Biotech to Announce Second Quarter 2009 Financial Results on July 23, 2009

  7/13/2009

• Trinity Biotech Receives FDA Approval for Destiny Max in the USA

  7/7/2009

• Trinity Biotech Announces First Quarter 2009 Financial Results

  4/29/2009

• Trinity Biotech to Announce First Quarter 2009 Financial Results

  4/22/2009

• Trinity Biotech Announces Quarter 4 Results

  3/10/2009

• Trinity Biotech Announces Commencement of TRI-stat(TM) CLIA Trials

  3/9/2009

• Trinity Biotech Announces Commencement of TRI-stat(TM) CLIA Trials

  3/9/2009

• Trinity Biotech to Announce Fourth Quarter and Fiscal 2008 Year-End Financial Results

  3/6/2009

• Trinity Biotech Announces Its First 3 Destiny Max Placements in the United Kingdom

  3/4/2009